Free Access
Med Sci (Paris)
Volume 19, Number 11, Novembre 2003
Page(s) 1101 - 1110
Section M/S Revues
Published online 15 November 2003
  1. Marceau F, Bachvarov DR. Kinin receptors. Clin Rev Allergy Immunol 1998; 16: 385–401. [Google Scholar]
  2. Couture R, Harrisson M, Vianna RM, Cloutier F. Kinin receptors in pain and inflammation. Eur J Pharmacol 2001; 429: 161–76. [Google Scholar]
  3. Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev 1992; 44: 1–80. [Google Scholar]
  4. Couture R, Lindsey CJ. Brain kallikrein-kinin system: from receptors to neuronal pathways and physiological functions. In: Quirion R, Björklund A, Hökfelt T, eds. Handbook of chemical neuroanatomy: peptide receptors, part I. Amsterdam: Elsevier, 2000; 16: 241–300. [Google Scholar]
  5. Décarie A, Raymond P, Gervais N, Couture R, Adam A. Serum interspecies differences in metabolic pathways of bradykinin and (desArg9) BK: influence of enalaprilat. Am J Physiol 1996; 271: H1340–7. [Google Scholar]
  6. Kuoppala A, Lindstedt KA, Saarinen J, Kovanen PT, Kokkonen JO. Inactivation of bradykinin by angiotensin-converting enzyme and by carboxypeptidase N in human plasma. Am J Physiol Heart Circ Physiol 2000; 278: H1069–74. [Google Scholar]
  7. Regoli D, Nsa Allogho S, Rizzi A, Gobeil FJ. Bradykinin receptors and their antagonists. Eur J Pharmacol 1998; 348: 1–10. [Google Scholar]
  8. Regoli D, Rizzi A, Perron SI, Gobeil F. Classification of kinin receptors. Biol Chem 2001; 382: 31–5. [Google Scholar]
  9. Marceau F, Hess JF, Bachvarov DR. The B1 receptors for kinins. Pharmacol Rev 1998; 50: 357–86. [Google Scholar]
  10. Velarde V, Ullian ME, Morinelli TA, Mayfield RK, Jaffa AA. Mechanisms of MAPK activation by bradykinin in vascular smooth muscle cells. Am J Physiol 1999; 277: C253–61. [Google Scholar]
  11. Adomeit A, Graness A, Gross S, Seedorf K, Wetzker R, Liebmann C. Bradykinin B2 receptor-mediated mitogen-activated protein kinase activation in COS-7 cells requires dual signaling via both protein kinase C pathway and epidermal growth factor receptor transactivation. Mol Cell Biol 1999; 19: 5289–97. [Google Scholar]
  12. Dray A. Kinins and their receptors in hyperalgesia. Can J Physiol Pharmacol 1997; 75: 704–12. [Google Scholar]
  13. Linz W, Wiemer G, Gohlke P, Unger T, Scholkens BA. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev 1995; 47: 25–49. [Google Scholar]
  14. Rhaleb NE, Yang XP, Nanba M, Shesely EG, Carretero OA. Effect of chronic blockade of the kallikrein-kinin system on the development of hypertension in rats. Hypertension 2001; 37: 121–8. [Google Scholar]
  15. Duka I, Kintsurashvili E, Gavras I, Johns C, Bresnahan M, Gavras H. Vasoactive potential of the B1 bradykinin receptor in normotension and hypertension. Circ Res 2001; 88: 275–81. [Google Scholar]
  16. Calixto JB, Cabrini DA, Ferreira J, Campos MM. Kinins in pain and inflammation. Pain 2000; 87: 1–5. [Google Scholar]
  17. Lortie M, Regoli D, Rhaleb NE, Plante GE. The role of B1- and B2-kinin receptors in the renal tubular and hemodynamic response to bradykinin. Am J Physiol 1992; 262: R72–6. [Google Scholar]
  18. Nakhostine N, Ribuot C, Lamontagne D, Nadeau R, Couture R. Mediation by B1 and B2 receptors of vasodepressor responses to intravenously administered kinins in anaesthetized dogs. Br J Pharmacol 1993; 110: 71–6. [Google Scholar]
  19. Phagoo SB, Poole S, Leeb- Lundberg LM. Autoregulation of bradykinin receptors: agonists in the presence of interleukin-1beta shift the repertoire of receptor subtypes from B2 to B1 in human lung fibroblasts. Mol Pharmacol 1999; 56: 325–33. [Google Scholar]
  20. Larrivée JF, Bachvarov DR, Houle F, Landry J, Huot J, Marceau F. Role of the mitogen-activated protein kinases in the expression of the kinin B1 receptors induced by tissue injury. J Immunol 1998; 160: 1419–26. [Google Scholar]
  21. Campos MM, Souza GEP, Calixto JB. In vivo B1 kinin receptor upregulation. Evidence for involvement of protein kinases and nuclear factor-κB pathways. Br J Pharmacol 1999; 127: 1851–9. [Google Scholar]
  22. Ganju P, Davis A, Patel S, Nunez X, Fox A. p38 stressactivated protein kinase inhibitor reverses bradykinin B1 receptor-mediated component of inflammatory hyperalgesia. Eur J Pharmacol 2001; 421: 191–9. [Google Scholar]
  23. Marin-Castano ME, Schanstra JP, Neau E, et al. Induction of functional bradykinin B1 receptors in normotensive rats and mice under chronic angiotensinconverting enzyme inhibitor treatment. Circulation 2002; 105: 627–32. [Google Scholar]
  24. Sabourin T, Guay K, Houle S, et al. Absence of ligandinduced regulation of kinin receptor expression in the rabbit. Br J Pharmacol 2001; 133: 1154–62. [Google Scholar]
  25. Bhoola K, Ramsaroop R, Plendl J, Cassim B, Dlamini Z, Naicker S. Kallikrein and kinin receptor expression in inflammation and cancer. Biol Chem 2001; 382: 77–89. [Google Scholar]
  26. Campos MM, Souza GE, Calixto JB. Modulation of kinin B1 but not B2 receptors-mediated rat paw edema by IL-1beta and TNFalpha. Peptides 1998; 19: 1269–76. [Google Scholar]
  27. Prat A, Biernacki K, Pouly S, Nalbantoglu J, Couture R, Antel JP. Kinin B1 receptor expression and function on human brain endothelial cells. J Neuropathol Exp Neurol 2000; 59: 896–906. [Google Scholar]
  28. Prat A, Weinrib L, Becher B, et al. Bradykinin B1 receptor expression and function on T lymphocytes in active multiple sclerosis. Neurology 1999; 53: 2087–92. [Google Scholar]
  29. Pesquero JB, Araujo RC, Heppenstall PA, et al. Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors. Proc Natl Acad Sci USA 2000; 97: 8140–5. [Google Scholar]
  30. Ferreira J, Campos MM, Pesquero JB, Araujo RC, Bader M, Calixto JB. Evidence for the participation of kinins in Freund’s adjuvant-induced inflammatory and nociceptive responses in kinin B1 and B2 receptor knockout mice. Neuropharmacology 2001; 41: 1006–12. [Google Scholar]
  31. Levy D, Zochodne DW. Increased mRNA expression of the B1 and B2 bradykinin receptors and antinociceptive effects of their antagonists in an animal model of neuropathic pain. Pain 2000; 86: 265–71. [Google Scholar]
  32. Rabinovitch A. An update on cytokines in the pathogenesis of insulindependent diabetes mellitus. Diabetes Metab Rev 1998; 14: 129–51. [Google Scholar]
  33. Yerneni KK, Bai W, Khan BV, Medford RM, Natarajan R. Hyperglycemia-induced activation of nuclear transcription factor kappa B in vascular smooth muscle cells. Diabetes 1999; 48: 855–64. [Google Scholar]
  34. Zuccollo A, Navarro M, Catanzaro O. Effects of B1 and B2 kinin receptor antagonists in diabetic mice. Can J Physiol Pharmacol 1996; 74: 586–9. [Google Scholar]
  35. Mage M, Pécher C, Neau, E, et al. Induction of B1 receptors in streptozotocin diabetic rats: possible involvement in the control of hyperglycemia-induced glomerular MAP-kinase activation. Can J Physiol Pharmacol 2002; 80: 328–33. [Google Scholar]
  36. Cloutier F, Couture R. Pharmacological characterization of the cardiovascular responses elicited by kinin B1 and B2 receptor agonists in the spinal cord of streptozotocin-diabetic rats. Br J Pharmacol 2000; 130: 375–85. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.